ProfileGDS4718 / 203957_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 69% 68% 82% 67% 67% 88% 84% 74% 62% 65% 74% 66% 78% 85% 80% 74% 69% 86% 85% 76% 72% 71% 69% 70% 68% 82% 66% 86% 68% 85% 83% 85% 66% 73% 83% 87% 83% 76% 65% 81% 67% 84% 82% 91% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.796269
GSM549102patient 115, normal, homogenized [OPG study]6.7283968
GSM549104patient 119, normal, homogenized [OPG study]8.1408782
GSM549108patient 138, normal, homogenized [OPG study]6.6375767
GSM549119patient 077, normal, homogenized [OPG study]6.5991167
GSM549133patient 032, cancer, homogenized [OPG study]8.9239588
GSM549139patient 042, cancer, homogenized [OPG study]8.4196884
GSM549099patient 107, normal, homogenized [OPG study]7.1575274
GSM549109patient 139, normal, homogenized [OPG study]6.2602762
GSM549110patient 046, normal, homogenized [OPG study]6.4347665
GSM549114patient 063, normal, homogenized [OPG study]7.2213274
GSM549122patient 082, normal, homogenized [OPG study]6.5862766
GSM549134patient 033, cancer, homogenized [OPG study]7.6558878
GSM549136patient 036, cancer, homogenized [OPG study]8.5853885
GSM549140patient 044, cancer, homogenized [OPG study]7.961280
GSM549111patient 047, normal, homogenized [OPG study]7.2527974
GSM549113patient 057, normal, homogenized [OPG study]6.7854269
GSM549132patient 031, cancer, homogenized [OPG study]8.5761486
GSM549137patient 038, cancer, homogenized [OPG study]8.4187285
GSM549142patient 047, cancer, homogenized [OPG study]7.2996676
GSM549100patient 110, normal, homogenized [OPG study]6.9547672
GSM549107patient 135, normal, homogenized [OPG study]6.9228671
GSM549115patient 068, normal, homogenized [OPG study]6.7795769
GSM549116patient 072, normal, homogenized [OPG study]6.8528670
GSM549120patient 078, normal, homogenized [OPG study]6.6963368
GSM549131patient 030, cancer, homogenized [OPG study]8.2127482
GSM549118patient 074, normal, homogenized [OPG study]6.5922366
GSM549129patient 027, cancer, homogenized [OPG study]8.5928586
GSM549123patient 088, normal, homogenized [OPG study]6.7515568
GSM549124patient 006, cancer, homogenized [OPG study]8.3113785
GSM549126patient 015, cancer, homogenized [OPG study]8.1855183
GSM549128patient 025, cancer, homogenized [OPG study]8.5290185
GSM549103patient 117, normal, homogenized [OPG study]6.4956666
GSM549117patient 073, normal, homogenized [OPG study]7.096973
GSM549138patient 041, cancer, homogenized [OPG study]8.2508583
GSM549141patient 045, cancer, homogenized [OPG study]8.8668787
GSM549130patient 028, cancer, homogenized [OPG study]8.1654683
GSM549101patient 111, normal, homogenized [OPG study]7.3738976
GSM549105patient 128, normal, homogenized [OPG study]6.5099465
GSM549106patient 134, normal, homogenized [OPG study]8.1428981
GSM549112patient 048, normal, homogenized [OPG study]6.5937567
GSM549125patient 011, cancer, homogenized [OPG study]8.257484
GSM549127patient 024, cancer, homogenized [OPG study]8.1279582
GSM549135patient 035, cancer, homogenized [OPG study]9.5211391